Prostate Cancer Screenings Fell Sharply Early in COVID-19 Pandemic
The decrease in prostate cancer screening rates was the smallest among 5 cancers studied.
Colon Cancer
Celecoxib Provides No Survival Benefit for Patients With Stage III Colon Cancer
Celecoxib failed to reduce the risk of recurrence in patients with colon cancer.
Updated Screening Guidelines for 5 Cancer Types
An update on the available cancer screening guidelines, benefits/limitations, and risks for cervical, breast, prostate, colon, and lung cancers.
Universal Health Care Associated With a Lower Risk of Death in Colon Cancer
Results suggest universal health care could reduce racial disparities in survival.
Cancer Diagnoses Increase at Age 65, Decrease Immediately Afterward
The largest increase in cancer diagnosis at age 65 years was in stage I for all breast cancer, colon cancer, prostate cancer, and lung cancer.
Colorectal Cancer: What Your Patients Need to Know
Although many Americans are at risk of developing colorectal cancer, they may not be aware of their own specific risk factors that they could have for it. What should medical professionals be teaching their patients about on regarding the risks, symptoms, detection, and prevention of colorectal cancer?
Colon Cancer Diagnosed Earlier Under Medicaid Expansion
Medicaid expansion also may result in improved access to treatment, including palliative care.
Surgical Skill Associated With Colon Cancer Survival Outcomes
Small study assessed surgical skills through submitted videos.
Neoadjuvant Immunotherapy Shows Promise in Early Colon Cancer
Immune checkpoint inhibition may even benefit some patients with MMR-proficient tumors.
Recurrence-Free and Overall Survival Better in Adult Patients With Colon Cancer
Patients older than 25 years have significantly higher rates of OS and RFS at 3 and 5 years compared with patients younger than 25.
- Loading...
Loading...
Next post in Colorectal Cancer
Loading... 
Loading...